Get started

Pennystocks

GOEV -Canoo reverses while TSLA slumps into earnings LONGGOEV was in the $ 4.50 to $5.50 range 1-2 months ago and on the 60 minute chart appears to be in a round bottom or doble bottom reversal concurrently with TSLA continuing to fall on the expectation of an earnings miss. GOEV's last earnings was a beat. It burned about half the cash that the analysts forecasted. The relative trend index indicator suggests a trend up is developing. A red flag is that volume is at or below the running mean. My plan is to watch GOEV for a rise in trading volumes before entertaining a long trade here. The Price Volume product Trend is helpful in that regard. While it currently has a positive slope it is minimal. I will watch for something a bit steeper. I am expecting the Price Momentum Oscillator will soon cross the horizontal zero and provide another entry signal.
NASDAQ:GOEVLong
by AwesomeAvani
1
Strong BUY BCG cmp 17.45, target 22.50/26.50 in few days Brightcom Group Ltd(BCG) offers digital marketing solutions to businesses, agencies and online publishers worldwide. Services Provided: The Company is divided into three major divisions: a. Ad-Tech and Digital Marketing: The services include Video Advertising, Display Ads Marketing, Performance-based Marketing, Search Marketing, Email Marketing and Lead Generation, Afliate Marketing, Social Marketing, Mobile Marketing, Niche Campaigns, Digital Trafc Management, Ad Serving b. Software services: The Company’s software services include developing customized technology platforms to solve specific needs of clients primarily around digital media and other related offerings c. Future technologies: The company’s future technologies division consists primarily of the Company’s LIFE product and developments in artificial intelligence, machine learning and Digital Out of Home(DOOH) advertising. Revenue Breakup - Q1FY24 Advertising Revenue : 94% Software Revenue : 5% Other Revenue : 1% Interim Order By SEBI An Interim order was passed by SEBI on 22.08.23 related to concerns regarding preferential allotment made by the company in FY20 & FY21. They suspected that money raised were given as loans and advances to its subsidiaries. It was also alleged that proper disclosures were not made in the Annual report and also disclosures related to preferential utilisation were not made. Post this the entire management of Brightcom has stepped down. Forensic Audit: SEBI ordered Forensic Audit of company on 16/09/2021 and Deloitte Touche Tohmatsu India LLP were appointed as forensic auditor w.r.t the financial statements from FY 2014-15 to FY 2019-20. The said Forensic Audit is under progress and the final outcome of the investigation is yet to come by the time of certification Market Cap - ₹ 3,513 Cr. Book Value - ₹ 34.7 Price to book value - 0.51 Debt - ₹ 0.00 Cr. EPS - ₹ 7.01 ROCE - 30.9 % Stock P/E - 2.51 Industry PE - 34.1 Currently the stock is terribly undervalued and we feel all the negatives is deeply discounted and technically it completely bottomed out at this valuation. We have recently the strong buying appearing and there is a good buying pattern emerging. So we strongly suggest a buy in BCG shares at 17.45 and buy till 18.5 for a target of 22.50 and 26.50. Valuation wise even at 26.5 its a buy but technically these are the resistance levels appearing. Stop loss 16
NSE:BCGLong
by PrashantDahale
1
ACB a Cannabis Penny Stock LONGACB is moving of late due to the legalization of marijuana in Germany as well as the election referendum in Florida in November. It is the best capitalized of the peer penny stocks in this sector. Today from the low at the opening bell to the high before the NY lunch hour, ACB moved about 30%. There was both a long and short trade here. The options moved multiples. National MJ Day is April 20th. I expect these stocks to keep moving at least until then. ACB is getting support from the mean anchored VWAP line and is able to run with its bullish momentum to the second upper VWAP line before the shorts take positions and longs realize profits. Since ACB is now situated at the mean VWAP, it is set up for a long entry now.
NASDAQ:ACBLong
by AwesomeAvani
1
ESPR a penny and medtech stock LONGESPR on the 120-minute chart is surging with momentum from an FDA approval for a new cholestrol and lipid medication which will be an alternative to the at statin class which has side effects and can cause diabetes. I am familar with a few of the professionals on the science advisory board they are researchers and academics of the highest claiber. The chart shows price testing and getting support from the mean VWAP and a little bit of resistance from the first upper VWAP line. I have added to my existing position at the consolidation at VWAP. I am well informed on ESPR market prospects; this could be disruptive. The dual time frame RSI of Chris Moody has curled up and validates the idea. My interim target is the double top of this past winter. I do expect increasing volume in time with the price action that follows. Disclaimer This a hot penny stock highly volatile - you could lose on this trade. Do not trade with money you cannot afford to lose. You must manage the trade well to realize profit. There are options if the put to call ratio is rising big money is pushing a reversal
NASDAQ:ESPRLong
by AwesomeAvani
CZOO moves up on the pre-earnings interest LONGCZOO shown on a reliable daily chart had an earnings report beating the estimates back in November whereprice action trended up then down in January followed by sideway action then finally a break out through VWAP band lines and the entirety of the high volume area of the profile. Ahead above is a volume void where price moved quickly coming down.. On the retrace, price can move through the void just as easily. The indicators show the volume pump and corresponding Price Volume Trend going exponential My first target is 23 about 90% upside - it is the line between the lows of the bottom wicks of Doji candles on 11/17 and 12/18/23. The stop loss is 12.6 just below the upper boundary of the high volume area. Once the price gets over 17, the stop loss will be converted to a trailing $2.00 stop loss and the risk free trade will continue higher. At the first target 50% will be realized and at the second another 25% while the remaining will be left to see if any momentum remains. The final target is 43 being the high pivots of early December 23 and the consolidation high volume area of October 23. the rest will look for the momentum fade while the stop loss is changed to trailing $1.00. This is potentially a 3-4X profit trade using alerts / notifications/ limits and stops. There will be very little screen time or effort in the management.
CLong
by AwesomeAvani
4
VOR - a b iotechnology penny stock LONGVOR is a on daily chart. It is a biotechnology startup which is burning cash. As a resut this is a speculative long trade for this company with products to treat leukemia ( blood cancer). Price has crossed over the POC line of the volume profile and also completed an anchored mean VWAP cross over. The Price Momentum Oscillator is reversing and buying volume has increased since the earnings report showed less of a loss than forecasted. I see 30% upside to the high pivot in mid-January. In conjunction with stop- loss set at the mean anchored VWAP this is a R to r of about 3.
NASDAQ:VOR
by AwesomeAvani
NKLA can this EV penny stock stop the cash burn/ News LONGNKLA on the 120 minute chart has been in a falling wedge pattern and had the news of hydrogen stations ready to go in the all important California market and now printed a countertrend breakout over the wedge. Can Nikola stop the cash burn? Can it prevent further shareholder dilution? Is the board protecting the interests of shareholders ? While this gets figured out can price rise to the anchored mean VWAP and put in a 10% jump in the short term? I intend to find out.
NASDAQ:NKLALong
by AwesomeAvani
OCGN pumps on dismissal of investor lawsuit LONGOCGN has been a great swing trade after buying bad news. The good news has replaced the bad. Earnings are in three days. Price well below ATH. November earnings were a beat meaning this risky Med Tech penny stock had a lower cash burn than projected. Now legal costs will disappear. Going long with a decent position expecting a better earnings. In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to Ocugen.
NASDAQ:OCGNLong
by AwesomeAvani
1
WULF a high volatility AI penny stock LONGWULF on a daily chart has room to run to a end of the year pivot high and the ATH of July 23 The relative trend indicator shows it rising out of of the chop zone and the RSI shows lines popping over 50. My targets are 3.1 and 3.8 the red lines from the tweezer tops. PRice has crossed the mean VWAP a bullish momentum stimulus. It is a cheap but risk way to take an entry in a swing trade long on WULF and the AI subsector of technology. Upside is 50-75% overall with a stop loss of 10% raised to break =even once price is 10% above entry and changed to 5% trailing once price is over 25% above the entry. This is a low time and effort type of trade meant to extract high profit relative to time/effort also with the use of alerts and notifications to manage the trade.
NASDAQ:WULFLong
by AwesomeAvani
TSHA a medtech penny stock pumps on news and earnings LONGTSHA is a gene technology medical company which reported on its clinical trials for Rett Syndrome which is a neurobehavioral disorder separate from others like autism or schizophrenia. This could be a breakthrough medication for those who suffer from Rett. TSHA102 could be heralded as a miracle treatment ( not a cure). Price had trended up in February and then down in March and is now situated at the mean anchored VWAP. Relative volumes are 5-10X the running mean. I am taking a sizeable position here based also on my background as well as the forecasts of medical technology stocks as being hot right now especially small caps. Risk is definitely on. TSHA has been selling off parts of its pipeline to fortify its core. This tells me leadership is realistic and has a survival plan which is a big plus in the world of young and small medical technology companies. The earnings report from yesterday showed a big earnings beat and a transition from cash burning to positive earnings. Part of this is from selling off part of its future. Nonetheless, that future may be very bright with what remains. I believe that TSHA will consolidate and gain consensus as to fair value but then resume bullish continuation. This may be a buy and hold until the next earnings while watching for clinical trial news that will give a hint as to the growth path.
NASDAQ:TSHALong
by AwesomeAvani
VINC Biotech Penny Stock Followup Swing TradesVINC was a penny stock and is now in the near penny category as this biotech stock has had a great run in the past 10 days. On the 30 minute chart, 225 shares are bought at low prices and 125 shares are sold for profit with 100 shares still running as the momentum slows. Overall, the trades where profitable averaging 12% daily in an average trade of 4.5 days. Time and effort in the trade were minimal as the price action was monitored by alerts and notifications as to price to moving average and moving average to moving average crosses as well as dips and peaks of RSI under 40 or over 70 to notify for potential buys or sells in this zig-zag strategy which intended to optimize profit and minimize time and effort in trading.
NASDAQ:VINCLong
by AwesomeAvani
BBAI - a penny stock in a hot sector LONGBBAI fell on an earnings miss on Thursday March 7th. The downtrend of 30% was basically a slow flush. Penny stocks are volatile to begin with; this one is in the hottest of subsectors. Price is in the hard oversold area just above the second lower VWAP line on this 15 minute while the RSI lines are in the mid-30s showing the price weakness. A predictive forecasting algo from Luxalgo suggests a bounce from the present price. I will take a long trade targeting a return of 25% over the next week with three targets and partial closures of 25% , 50 and 25% respectively with the targets shown on the chart. The stop loss is 2.50 just below the pivot low of 2.5. This trade idea demonstrates how penny stocks have great volatility and how if entered well can result in 25% weekly which if compounded regularly can result in rapid account balance growth overall. The trade is to be managed with partial closures directed by alerts and notifications as well as a trailing stop loss of 5% once the price gain has reached 10-15%. This minmizes effort and screen time so that they can be spread across a wider variety of trades.
NYSE:BBAILong
by AwesomeAvani
1
MVIS Microvision breaks higher from earnings LONGMVIS is a volatile penny stock with daily volumes in the 20JK range and a low float. Yesterday was a decent earnings beat. MVIX was already trending up into the earnings and now may sustain that trend up. Volatility and volume indicator support my supposition that the trend is real. The target of the consolidation period of February 8-13's price level of 2.58 is 13 % upside. I espect this to be a long swing trade lasting a few days. Upon reaching the target I will take half the position to realize that part of the profit and run the rest.
NASDAQ:MVISLong
by AwesomeAvani
BLUE- a biotechnology earnings penny stock LONGBLUE a week ago had a bull run to gain 90% in 5 days and then reversed into a standard Fibonacci retracement on the 30-minute chart, then in consolidation for a day or two getting support from the mean anchored VWAP. The last trading day was a quick rise with momentum in a bull flag. Earnings are coming. I will take another long trade on BLU into earnings. My target is 1.90 about the high of the prior trend up and below the second VWAP line above the mean. A tight stop loss at 1.53 ( below the flag's consolidation) will make it more likely the trade will be a 20% winner. I have taken call options strikng $1.50 for March 15th for $20 each. or a small loss of 2-3%
NASDAQ:BLUELong
by AwesomeAvani
MYO can Myomo continue the push to the earnings report?MYO had impressive week gaining over 35%. It is a volatile penny biotechnology stock with good earnings back in November new due for another report. On a 120 minute chart with relative volatility and volume indicators and a volume profile added. The volume and volativlty of this past week's move is obvious. Price gain has slowed on the approach to the POC line of the volume profile which appears to be resistance. Price may break that resistance but could get rejected there. I plan to buy MYO long on a break of resistance with a buy stop set at 4.04 and a stop loss at 3.96. If MYO rises and gets over 4.04 the order should fill and if it retests the POC line as support and the support fails, the stop will close the trade. My expectation however is for the earnings run to take it to the level of the pivot high in early January for a 25% gain.
AMEX:MYOLong
by AwesomeAvani
EXFY a fintech penny stock at 5% of the ATH LONGEXFY recently had an earnings beat and has bullish momentum. While on a sixty minute chart it may appear to be overextended, in the context of an all-time-high of about $50 perhaps it has as much as 20X upside. EXFY rose from the earnings beat and then retraced and reversed the retracement. I see it as a long wing trade perhaps until the approach to the next earnings. The volume and volatility indicators suggest bullish momentum is strong and may continue.
NASDAQ:EXFYLong
by AwesomeAvani
10
LEXX a penny medical stock LONGLEXX on the daily chart is on a big bullrun breaking out of an ascending broadening triangle or megaphone pattern demostrative of increasing volatility. Retlative volumes are 2X the historical comparison. Price is now on the approach to the highs of 2023 but is only 15% of the all high highs of 19 at the neckline of a head and shoulders back in 2018-2019, In short it has a lot of upside if it can show earnings growth on higher revenues. For now targets are 4.15 the high of 2022 and 6.45 the high of 2021 marked on the chart in black horizontal lines. LEXX is a money burning medical penny it is high risk like its peers. The reward potential is as much as 7X and more realistically 2X in the intermediate term. I will so long here with the risk in mind in the context of the reward potential.
NASDAQ:LEXXLong
by AwesomeAvani